MSF Scientific Days, London 2019 Posters Day One – Research Slides Welcome and introduction Session 3 Vickie Hawkins, Executive Director, MSF UK Taking refuge in the city: the humanitarian response to urban crises Session 1 Chair: Mala Rao, Senior Clinical Fellow, Imperial Failing interventions, resistant bugs College London, National Medical Adviser, NHS Chair: Caroline Voûte, Health Policy Advisor, MSF England's Workforce Race Equality Strategy, and Vice Chair WaterAid UK • Antiretroviral drug resistance and third-line treatment outcomes amongst HIV patients failing Keynote: James Orbinski, Professor and Inaugural second-line therapy in Malawi, David Maman, MSF Director, Dahdaleh Institute for Global Health • ¨Without antibiotics, I cannot treat” - prescribing Research, York University practices in West Bengal, India: mixed methods Panellist: Willemieke van den Broek, Medical study, Mohit Nair, MSF Coordinator, MSF • Implementation of directly observed treatment pre-resistance testing for patients failing second- • Session 3 Panel Discussion line antiretroviral therapy, Maputo, Mozambique, • Reflection on Session Three, Muneera Williams, Robert Deiss, MSF poet • Integrated vector control strategies for malaria Session 4 prevention in Nduta refugee camp, Tanzania, Claire Dorion, MSF Still neglected? Overlooked and forgotten • Session 1 Q&A Chair: Ian Cropley, Consultant, Infectious Diseases and • Reflection on Session One, Muneera Williams, poet HIV, Royal Free Hospital Session 2 • Liposomal amphotericin B as monotherapy and in Power, participation, and people combination with miltefosine for treatment of visceral leishmaniasis in HIV-positive patients: a Chair: Lisa Schwartz, Arnold L. Johnson Chair in Health randomised trial from Bihar, India, Sharwar Kazmi, Care Ethics, McMaster University MSF • Pre-exposure prophylaxis for HIV prevention in the • Prevalence of and beliefs about noma in northwest public healthcare system in Eswatini, Nqobile Nigeria: a mixed-methods study, Modupe Juliana Mmema, MSF Oyemakinde, MSF • Refused and referred: persistent stigma and • Outcomes of visceral leishmaniasis in pregnancy: discrimination amongst people living with HIV in retrospective cohort, South Sudan, Judith Bihar, India, Mohit Nair, MSF Pekelharing, MSF • “Nothing in the world can serve those people like • Two antivenoms for snakebite in Agok, South Sudan: palliative care”: qualitative analysis of refugee and a prospective monitoring study, Gabriel Alcoba, MSF provider experiences in Jordan, Rwanda and • Evaluating new regimens for the treatment of Bangladesh, Rachel Yantzi, McMaster University chronic Chagas disease: BENDITA, a randomised • Management of acute malnutrition in children trial, Fabiana Barreira, DNDi aged 6 to 59 months: OptiMA pilot trial in rural • Session 4 Q&A Burkina Faso, Maguy Daures, The Alliance for • Reflection on Session Four, Muneera Williams, poet International Medical Action Poster prize winner and closing remarks • Session 2 Q&A • Reflection on Session Two, Muneera Williams, poet Kiran Jobanputra, Head of the Manson Unit and Deputy Medical Director, MSF Operational Centre Turbo talks Amsterdam MSF Scientific Days, London 2019 Slides Day Two - Innovation Welcome and introduction Session 3 Nan Buzard (MC), Head of Innovation, International The devil’s in the data: ensuring a people-first Committee of the Red Cross approach in tech innovation Keynote: Eddie Obeng, CEO of Pentacle Business Chair: Ivan Gayton, Humanitarian OpenStreetMap School and Professor of the School of Team Entrepreneurship and Innovation at Henley Business Panel discussion: School • Silvia Moriana, Innovation and Transformation Session 1 Lead, Operational Centre Barcelona, MSF One to another: innovation in social engagement • Paul Wicks, Vice President of Innovation, PatientsLikeMe Chair: Anni Beukes, Institute Resident Fellow, • Precious Lunga, CEO and co-founder, Baobab Mansueto Institute for Urban Innovation, University of Circle Chicago • Alexandrine Pirlot de Corbion, Global South • When your story becomes our story: learning from Programme Lead, Privacy International a co-created noma health promotion pilot in Session 4 Nigeria, Annette de Jong, MSF • Using social media for patient and community Prioritising health and dignity for mothers and engagement: MSF’s experience in Lebanon, Jinane children in humanitarian contexts Saad, MSF Chair: Kamalini Lokuge, Senior Research Fellow & • Experts-by-experience: building survivor advocacy Lead, Humanitarian Health Research Initiative, at the Victims of Torture rehabilitation clinic, Australian National University Athens, Ben du Preez, MSF and Touria, Survivors2 • Session 1 Q&A • Implementing neonatal palliative care in Afghanistan, Nikola Morton, MSF Session 2 • Overcoming barriers to provision of safe abortion Let’s get physical: innovation in a material world care in MSF projects: Task Force approach, Manisha Kumar, MSF Chair: Hayaatun Sillem, Chief Executive, Royal • Obstetric innovations in Kabala Hospital, Sierra Academy of Engineering, UK Leone: the Bubble Operating Theatre and Non- • Indoor household use of attractive toxic sugar baits Pneumatic Anti-Shock Garment, Sonia Guinovart, on malaria vectors, Tchonka, Democratic Republic MSF of Congo, Maite Guardiola, MSF Innovation Day Feedback, Muneera Williams, poet • Using the sun to power air conditioning, Marpe Tanaka, MSF Closing Remarks • Development of an all-in-one transportable clinical Kiran Jobanputra, Head of the Manson Unit, and bacteriology laboratory: feedback from testing a Deputy Medical Director, MSF Operational Centre Mini-Lab prototype, Jean-Baptiste Ronat, MSF Amsterdam • Developing a gravity-fed water treatment facility for MSF projects in Balochistan, Pakistan, Farooq Khan, MSF • Session 2 Q&A Demo elevator pitches .